{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:12:35Z","timestamp":1759335155594,"version":"build-2065373602"},"reference-count":43,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.eprac.2025.07.019","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T23:49:33Z","timestamp":1753919373000},"page":"1256-1264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characteristics of Primary Aldosteronism in a Hypertensive Cohort From Central China"],"prefix":"10.1016","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5827-2197","authenticated-orcid":false,"given":"Rui","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zegang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengliang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eprac.2025.07.019_bib1","first-page":"3","article-title":"Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome","volume":"45","author":"Conn","year":"1955","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.eprac.2025.07.019_bib2","doi-asserted-by":"crossref","first-page":"E773","DOI":"10.1503\/cmaj.161486","article-title":"Primary aldosteronism: a common cause of resistant hypertension","volume":"189","author":"Kline","year":"2017","journal-title":"CMAJ"},{"key":"10.1016\/j.eprac.2025.07.019_bib3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/s41581-023-00753-6","article-title":"Primary aldosteronism: molecular medicine meets public health","volume":"19","author":"Azizan","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.eprac.2025.07.019_bib4","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.eprac.2025.07.019_bib5","doi-asserted-by":"crossref","first-page":"900","DOI":"10.3390\/ijms25020900","article-title":"What we know about and what is new in primary aldosteronism","volume":"25","author":"Ekman","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.eprac.2025.07.019_bib6","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism \u2014 a multidimensional syndrome","volume":"18","author":"Turcu","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.eprac.2025.07.019_bib7","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.mayocp.2023.04.023","article-title":"Primary aldosteronism: a pragmatic approach to diagnosis and management","volume":"98","author":"Dogra","year":"2023","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.eprac.2025.07.019_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1161\/CIRCULATIONAHA.123.066389","article-title":"Subclinical primary aldosteronism and cardiovascular health: a population-based cohort study","volume":"149","author":"Hundemer","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.eprac.2025.07.019_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.030142","article-title":"Adverse effects of aldosterone: beyond blood pressure","volume":"13","author":"Brown","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.eprac.2025.07.019_bib10","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/HYPERTENSIONAHA.121.18118","article-title":"Screening rates for primary aldosteronism among individuals with hypertension plus hypokalemia: a population-based retrospective cohort study","volume":"79","author":"Hundemer","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.eprac.2025.07.019_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/j.ajkd.2023.01.447","article-title":"Underdiagnosis of primary aldosteronism: a review of screening and detection","volume":"82","author":"Funes Hernandez","year":"2023","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.eprac.2025.07.019_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/archinte.1981.00340130033011","article-title":"A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients","volume":"141","author":"Hiramatsu","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eprac.2025.07.019_bib13","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1016\/j.jfma.2023.04.019","article-title":"Aldosterone-to-Renin Ratio (ARR) as a screening tool for Primary Aldosteronism (PA)","volume":"123","author":"Lin","year":"2024","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.eprac.2025.07.019_bib14","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(21)00210-2","article-title":"Diagnosis and treatment of primary aldosteronism","volume":"9","author":"Reincke","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eprac.2025.07.019_bib15","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.019_bib16","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","article-title":"Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Mulatero","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.eprac.2025.07.019_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s12149-023-01851-y","article-title":"Advances in the molecular imaging of primary aldosteronism","volume":"37","author":"Ren","year":"2023","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.eprac.2025.07.019_bib18","doi-asserted-by":"crossref","first-page":"e837","DOI":"10.1210\/clinem\/dgad451","article-title":"Predicting bilateral subtypes of primary aldosteronism without adrenal vein sampling: a systematic review and meta-analysis","volume":"109","author":"Ng","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.019_bib19","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1507\/endocrj.EJ21-0508","article-title":"Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021","volume":"69","author":"Naruse","year":"2022","journal-title":"Endocr J"},{"key":"10.1016\/j.eprac.2025.07.019_bib20","first-page":"727","article-title":"Expert consensus on diagnosis and treatment of primary aldosteronism (2020 edition) [in Chinese]","volume":"36","author":"Wang","year":"2020","journal-title":"Chin J Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.019_bib21","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.eprac.2025.07.019_bib22","doi-asserted-by":"crossref","first-page":"e1708","DOI":"10.1210\/clinem\/dgaa974","article-title":"Development of a prediction score to avoid confirmatory testing in patients with suspected primary aldosteronism","volume":"106","author":"Burrello","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.019_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1093\/ejendo\/lvaf117","article-title":"Expert Consensus on the Primary Aldosteronism Severity Classification and its strategic application in indicating adrenal venous sampling","volume":"193","author":"Murakami","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2025.07.019_bib24","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.ecl.2019.08.002","article-title":"Primary aldosteronism diagnosis and management: a clinical approach","volume":"48","author":"Hundemer","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.eprac.2025.07.019_bib25","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1152\/physrev.00026.2015","article-title":"Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney","volume":"96","author":"Stowasser","year":"2016","journal-title":"Physiol Rev"},{"key":"10.1016\/j.eprac.2025.07.019_bib26","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/s41440-023-01288-w","article-title":"Recent progress in the diagnosis and treatment of primary aldosteronism","volume":"46","author":"Yoshida","year":"2023","journal-title":"Hypertens Res"},{"key":"10.1016\/j.eprac.2025.07.019_bib27","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/ejendo\/lvac002","article-title":"International multicenter survey on screening and confirmatory testing in primary aldosteronism","volume":"188","author":"Naruse","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.eprac.2025.07.019_bib28","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1515\/cclm-2024-1312","article-title":"Screening primary aldosteronism by plasma aldosterone-to-angiotensin II ratio","volume":"63","author":"Lo","year":"2025","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.eprac.2025.07.019_bib29","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1210\/clinem\/dgab348","article-title":"Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism","volume":"106","author":"Hung","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.019_bib30","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/HYPERTENSIONAHA.124.22642","article-title":"Clinical management of primary aldosteronism: an update","volume":"81","author":"Rossi","year":"2024","journal-title":"Hypertension"},{"key":"10.1016\/j.eprac.2025.07.019_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/cen.13943","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a systematic review and meta-analysis","volume":"90","author":"Wu","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2025.07.019_bib32","doi-asserted-by":"crossref","first-page":"e866","DOI":"10.1210\/clinem\/dgaa812","article-title":"Significance of discordant results between confirmatory tests in diagnosis of primary aldosteronism","volume":"106","author":"Fukumoto","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.019_bib33","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/HYPERTENSIONAHA.107.091827","article-title":"Comparison of the captopril and the saline infusion test for excluding aldosterone-producing adenoma","volume":"50","author":"Rossi","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.eprac.2025.07.019_bib34","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.eprac.2025.07.019_bib35","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa282","article-title":"Development and validation of criteria for sparing confirmatory tests in diagnosing primary aldosteronism","volume":"105","author":"Wang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.019_bib36","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41440-020-0454-9","article-title":"Comparison of the shortened and standard saline infusion tests for primary aldosteronism diagnostics","volume":"43","author":"Yamashita","year":"2020","journal-title":"Hypertens Res"},{"key":"10.1016\/j.eprac.2025.07.019_bib37","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/cen.14134","article-title":"A combination of captopril challenge test after saline infusion test improves diagnostic accuracy for primary aldosteronism","volume":"92","author":"Lin","year":"2020","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.eprac.2025.07.019_bib38","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eprac.2025.07.019_bib39","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1210\/jc.2017-01774","article-title":"Significance of computed tomography and serum potassium in predicting subtype diagnosis of primary aldosteronism","volume":"103","author":"Umakoshi","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.eprac.2025.07.019_bib40","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/HJH.0000000000002348","article-title":"Aldosterone-potassium ratio predicts primary aldosteronism subtype","volume":"38","author":"Puar","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.eprac.2025.07.019_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55609","article-title":"Accuracy of gallium-68 pentixafor positron emission tomography\u2013computed tomography for subtyping diagnosis of primary aldosteronism","volume":"6","author":"Hu","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eprac.2025.07.019_bib42","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1038\/s41440-023-01347-2","article-title":"Optimizing adrenal vein sampling in primary aldosteronism subtyping through LC-MS\/MS and secretion ratios of aldosterone, 18-oxocortisol, and 18-hydroxycortisol","volume":"46","author":"Chang","year":"2023","journal-title":"Hypertens Res"},{"key":"10.1016\/j.eprac.2025.07.019_bib43","article-title":"Comparison of different diagnostic criteria of 68Ga-pentixafor PET\/CT for the classification of primary aldosteronism","volume":"110","author":"Zhang","year":"2024","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X25009796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:44:19Z","timestamp":1759301059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X25009796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1530891X25009796"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2025.07.019","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics of Primary Aldosteronism in a Hypertensive Cohort From Central China","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2025.07.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AACE. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}